Lawyer - News

Merck has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. As part of the agreement Merck must submit all new TV commercials for its drugs to the FDA for review before they can be aired. Another provision bars the company from "ghostwriting," a practice in which academic scientists were allegedly paid to take credit for positive research articles prepared by company-hired medical writers.

This entry was posted on Wednesday, May 21st, 2008 at 12:07 pm and is filed under Lawyer - News.